Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:10 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Variation in Sulphonylurea Response in Type 2 Diabetes
NCT00738088 · NHS Tayside · PHASE4 · terminated · last registry update 2018-05-03 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Following Regulator inspection in 2009, study terminated as inadequate approvals were in place” | – | Registry record, NHS Tayside |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against KCNJ11 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2018-11-26Phase 3 first posted: Farid Masoud, Topical Herbal Solution + Topical Minoxidil 5% (NCT03753113)
- 2018-10-22Phase 3 first posted: Soleno Therapeutics, Inc., DCCR + DCCR (NCT03714373)
- 2018-10-19Results posted on the registry: Eli Lilly and Company, Tolbutamide + Tasisulam (NCT01185548)
- 2018-10-19Also stopped (terminated): Eli Lilly and Company, Tolbutamide + Tasisulam (NCT01185548)
- 2018-09-13Results posted on the registry: University of Washington, Linagliptin + Glipizide (NCT02608177)
- 2018-02-22Phase 3 first posted: Soleno Therapeutics, Inc., DCCR + Placebo for DCCR (NCT03440814)
- 2017-10-26Results posted on the registry: University of Dundee, Gliclazide MR + Sitagliptin (NCT00780715)
- 2017-10-18Phase 3 first posted: Sherief Abd-Elsalam, Cabergoline + Gliclazide (NCT03313661)
- 2017-10-17Results posted on the registry: University of California, San Diego, recombinant human chorionic gonadotropin + Recombinant human follicle stimulating hormone (NCT00989781)
- 2017-10-13Results posted on the registry: National Institute of Mental Health (NIMH), Diazoxide + Placebo (NCT02049385)
- 2017-10-13Also stopped (terminated): National Institute of Mental Health (NIMH), Diazoxide + Placebo (NCT02049385)
- 2017-06-05Results posted on the registry: Arbelaez, Ana Maria, placebo + repaglinide (NCT00763412)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision